Pharmapar
Pharmapar is a family-owned Montreal-based distributor, founded in 1998, that supplies generic drugs to privately-insured individuals in Canada. It operates with 11-50 employees and a Canada-only footprint.
- Company typePrivate
- Founded1998
- HeadquartersMontreal, Canada
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Pharmapar does
Pharmapar is a family-owned Canadian pharmaceutical distributor headquartered in Montreal, founded in 1998. According to its firmographics, the company specializes in distributing generic drugs to privately-insured individuals in Canada, operating with a headcount of 11-50 employees.
The company's business model centers on generics distribution — a high-volume, low-margin segment of the pharmaceutical supply chain — channeling generic formulations through privately-insured channels rather than public formularies. As a family-owned private business, Pharmapar operates without external funding rounds or public-company disclosure obligations, and no pricing model, go-to-motion, customer segmentation, or contract economics are publicly described. The only documented third-party relationship is a website/branding link to KPI Tech (kpi-tech.ca), the nature of which is unspecified.
Operationally, the company maintains an active status but its public web presence is a placeholder ("Site en construction") with no substantive product catalog, technology stack disclosure, management team listing, certifications, or partnership details available. No proprietary technology, AI/ML capabilities, patents, certifications, regulatory actions, M&A activity, leadership changes, or product launches are disclosed in the available data. The operating footprint is described as Canada, with no broader geographic reach claimed.
Pharmapar firmographics
Firmographics- Name
- Pharmapar
- Website
- https://pharmapar.ca
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Pharmapar is a family-owned Montreal-based distributor, founded in 1998, that supplies generic drugs to privately-insured individuals in Canada. It operates with 11-50 employees and a Canada-only footprint.
- Ownership category
- akta.pro rank
Pharmapar industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Retail & Community Pharmacies (Chain/Independent) (HLAFALAA)
Keywords
Where Pharmapar is headquartered
LocationHeadquarters
- HQ city
- Montreal
- HQ country
- Canada
- HQ region
- North America
Markets served
Pharmapar business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Supply Chain, Operations, Personnel
Pharmapar product offering
Product offeringCore offering
Pharmapar is a family-owned business that distributes generic pharmaceutical drugs. The company focuses on serving privately-insured individuals in the Canadian market, providing access to generic medication alternatives as its core product offering.
Product overview
The Pharmapar website is currently under construction ("Site en construction") with no product or service information available. The site displays a placeholder page indicating development is in progress.
Differentiator
Problem solved
Functional benefit
Companies that use Pharmapar
Customer profileIdeal customer profiles1 record
Pharmapar technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Pharmapar partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- KPI TechunclearA logo linking to KPI Tech (http://www.kpi-tech.ca) appears on the Pharmapar website. The nature of the relationship is unclear as the site is under construction and no explicit partnership details are provided.
Recent moves3 records
Expansion highlights2 records
Pharmapar competitors and assessment
Company assessmentDirect peers
- Cencora (formerly AmerisourceBergen) Canada: Global pharmaceutical distribution giant with Canadian operations serving retail pharmacies, hospitals, and specialty channels. Comparable as a wholesale competitor, though significantly larger.
- McKesson Canada: The largest pharmaceutical wholesaler in Canada, distributing brand and generic drugs to pharmacies nationwide. Directly comparable to Pharmapar as a Canadian drug distributor, though at vastly greater scale.
- Kohl & Frisch: Canadian pharmaceutical wholesaler distributing to independent and chain pharmacies across Canada. Directly comparable to Pharmapar's generics distribution business.
Regional players
- Familiprix: Quebec-headquartered independent pharmacy banner with strong private-plan exposure. Comparable as a regional dispenser of generics in the same Quebec geography as Pharmapar.
- London Drugs: Western Canadian retail pharmacy chain operating in-store dispensaries serving private and public plans. Comparable as a multi-province retail generics dispenser, with partial geographic overlap to Pharmapar.
- Uniprix: Quebec pharmacy network dispensing brand and generic medications to insured patients. Comparable as a regional private-insurance generics channel based in the same home market as Pharmapar.
Others
- Pharmascience: Major Canadian generic drug manufacturer supplying wholesalers and pharmacy chains. Comparable as a counterpart in the Canadian generics value chain, sitting upstream of Pharmapar's distribution role.
- Apotex: Canada's largest generic pharmaceutical manufacturer, producing finished generic dosage forms for the Canadian market. Comparable as an upstream supplier and ecosystem participant to a Canadian generics distributor like Pharmapar.
Broad incumbents
- Shoppers Drug Mart (Loblaw Companies): Canada's largest retail pharmacy chain, dispensing generics and serving both publicly and privately-insured patients. Comparable as a generics dispenser and channel owner, though via retail rather than wholesale.
- Jean Coutu Group (PJC): Quebec-based pharmacy chain with broad retail pharmacy operations including generic dispensing. Comparable as a regional privately-insured generics channel, with overlap in the Quebec market where Pharmapar is based.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights4 records
Customer concentration
Pharmapar social profiles
Digital presencePharmapar financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pharmapar leadership team
Management profileNumber of profiles
Pharmapar funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pharmapar M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pharmapar
What does Pharmapar do?
Pharmapar is a family-owned business that distributes generic pharmaceutical drugs. The company focuses on serving privately-insured individuals in the Canadian market, providing access to generic medication alternatives as its core product offering.
When was Pharmapar founded?
Pharmapar was founded in 1998. It employs 11 to 50 people.
Where is Pharmapar based?
Pharmapar is headquartered in Montreal, Canada, in the North America region.
Who are Pharmapar's main competitors?
Direct peers on record are Cencora (formerly AmerisourceBergen) Canada, McKesson Canada and Kohl & Frisch. Regional players are Familiprix, London Drugs and Uniprix. Others are Pharmascience and Apotex. Broad incumbents are Shoppers Drug Mart (Loblaw Companies) and Jean Coutu Group (PJC).
Does Pharmapar have an API?
No public API is recorded for Pharmapar.
What industry is Pharmapar in?
Pharmapar's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAFALAA, Retail & Community Pharmacies (Chain/Independent). Its NAICS code is 424210 and its SIC code is 5122.